SpecificityAnti-ACE2 has no cross response to ACE1.
Species ReactivityHuman, Mouse, Rat
Immunogen DescriptionAnti-ACE2 antibody (R-1949-100) was raised against a peptide corresponding to 14 amino acids near the amino terminus of human ACE2.
The immunogen is located within the first 50 amino acids of ACE2.
ConjugateUnconjugated
Concentration1 mg/mL
Purity DescriptionAffinity-purified via peptide column.
Antibody validated: Western Blot in human, mouse and rat samples; Immunohistochemistry in human samples; Immunofluorescence in human samples. All other applications and species not yet tested.
TargetAngiotensin converting enzyme 2 (ACE2)
SpecificityAnti-ACE2 has no cross response to ACE1.
Target Host SpeciesHuman
Species ReactivityHuman, Mouse, Rat
Antibody HostRabbit
Antibody TypePolyclonal
Antibody IsotypeIgG
ConjugateUnconjugated
Immunogen DescriptionAnti-ACE2 antibody (R-1949-100) was raised against a peptide corresponding to 14 amino acids near the amino terminus of human ACE2.
The immunogen is located within the first 50 amino acids of ACE2.
HomologyPredicted species reactivity based on immunogen sequence: Bovine: (86%)
Positive ControlHuman kidney tissue lysate, human spleen tissue lysate, human testis tissue lysate
Purity DescriptionAffinity-purified via peptide column.
FormatLiquid. ACE2 Antibody is supplied in PBS containing 0.02% sodium azide. Conc.1 mg/mL
Concentration1 mg/mL
Reconstitution InstructionsSpin vial briefly before opening.
Storage InstructionsACE2 antibody can be stored at 2-8°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Batch NumberPlease see item label.
Expiration Date12 months after date of receipt (unopened vial).
NCBI Official Full Nameangiotensin I converting enzyme (peptidyl-dipeptidase A) 2
NCBI Official SymbolACE2
NCBI OrganismHomo sapiens
Scientific Background
ACE2 Antibody: Angiotensin-converting enzyme 2 (ACE2) plays a central role in vascular, renal, and myocardial physiology. In contrast to its homolog ACE, ACE2 expression is restricted to heart, kidney, and testis. Recently. ACE2 has also been shown to be a functional receptor of the SARS coronavirus. Homology modeling shows 2019-nCoV has a similar receptor-binding domain structure as SARS-CoV, which suggests COVID-19 (2019-nCoV) may use ACE2 as a receptor in humans for infection. The normal function of ACE2 is to convert the inactive vasoconstrictor angiotensin I (AngI) to Ang1-9 and the active form AngII to Ang1-7, unlike ACE, which converts AngI to AngII. While the role of these vasoactive peptides is not well understood, lack of ACE2 expression in ace2-/ace2- mice leads to severely reduced cardiac contractility, indicating its importance in regulating heart function.
Figure 1 Independent Antibody Validation (IAV) via Protein Expression Profile in Human Tissues
Loading: 15 μg of lysates per lane.
Antibodies: ACE2, R-1937-100 (2 μg/mL), ACE2, R-1939-100 (2 μg/mL), ACE2, R-1949-100 (2 μg/mL) and beta-actin (1 μg/mL), 1h incubation at RT in 5% NFDM/TBST.
Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.
Figure 2 Western Blot Validation in Human Tissues
Loading: 15 μg of lysates per lane.
Antibodies: ACE2, R-1949-100 (1 μg/mL), 1h incubation at RT in 5% NFDM/TBST.
Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.
Figure 3 Western Blot Validation in Mouse Tissues
Loading: 15 μg of lysates per lane.
Antibodies: ACE2, R-1949-100 (2 μg/mL), 1h incubation at RT in 5% NFDM/TBST.
Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.
Figure 4 Western Blot Validation in Rat Thymus Tissue
Loading: 15 μg of lysates per lane.
Antibodies: ACE2, R-1949-100 (2 μg/mL), 1h incubation at RT in 5% NFDM/TBST.
Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.
Figure 5 Immunohistochemistry Validation of ACE2 in Human Kidney Tissue
Immunohistochemical analysis of paraffin-embedded human kidney tissue using anti-ACE2 antibody (R-1949-100) at 2 μg/mL. Tissue was fixed with formaldehyde and blocked with 10% serum for 1 h at RT; antigen retrieval was by heat mediation with a citrate buffer (pH6). Samples were incubated with primary antibody overnight at 4 °C. A goat anti-rabbit IgG H&L (HRP) at 1/250 was used as secondary. Counter stained with Hematoxylin.
Figure 6 Immunofluorescence Validation of ACE2 in Human Testis Tissue Immunofluorescent analysis of 4% paraformaldehyde-fixed human testis tissue labeling ACE-2 with R-1949-100 at 20 μg/mL, followed by goat anti-rabbit IgG secondary antibody at 1/500 dilution (green) and DAPI staining (blue).
Figure 7 Immunofluorescence Validation of ACE2 in Human Lung Tissue Immunofluorescent analysis of 4% paraformaldehyde-fixed human lung tissue labeling ACE-2 with R-1949-100 at 20 μg/mL, followed by goat anti-rabbit IgG secondary antibody at 1/500 dilution (green) and DAPI staining (blue).
General ReferencesDonoghue et al. Circ. Res. 2000;87:1-9. Tipnis et al. J Biol. Chem. 2000;275:33238-43. Li et al. Nature 2003;426:450-4. Lu et al. The Lancet 2020 (published online). Crackower et al. Nature 2002;417:822-8.